But it demonstrates FOXO4-DRI works on human senescent cells and has potential applications in regenerative medicine beyond systemic aging
It is not approved by the FDA or any regulatory authority for human use, veterinary use, clinical administration, therapeutic applications, or diagnostic procedures
MH: Data curation, Formal Analysis, Funding acquisition, Investigation, Project administration, Software, Supervision, Visualization, Writingreview and editing
BAT-specific disruption of ERAD results in abnormal mitochondrial morphology, impaired heat production, and increased cold sensitivity, highlighting the importance of ERAD in adaptive thermogenesis
Lets face it: avoiding chemicals in our modern world is nearly impossible
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
